Shenyang Xingqi Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 770.35 million compared to CNY 469.35 million a year ago. Revenue was CNY 770.35 million compared to CNY 469.35 million a year ago. Net income was CNY 156.07 million compared to CNY 53.73 million a year ago. Basic earnings per share from continuing operations was CNY 1.9 compared to CNY 0.65 a year ago. Diluted earnings per share from continuing operations was CNY 1.9 compared to CNY 0.65 a year ago.